PAR1 anticorps

N° du produit ABIN969339

Cité dans 2+ publications. Cet anticorps anti-PAR1 est un anticorps Monoclonal produit chez le Souris, détectant PAR1 dans ELISA. Convient pour Humain.

Aperçu rapide pour PAR1 anticorps (ABIN969339)

Antigène: PAR1 (F2R) (Coagulation Factor II (thrombin) Receptor (F2R))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp PAR1 est non-conjugé

Application: ELISA

Clone: 6A7H10

Détail du produit anti-PAR1 anticorps

Fonction: PAR1 Antibody

Purification: Ascitic fluid

Immunogène: Purified recombinant fragment of PAR1 expressed in E. Coli.

Isotype: IgG1

Information d'application

Indications d'application: ELISA: 1/10000

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Ascitic fluid containing 0.03 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.

Références pour anticorps anti-PAR1 (ABIN969339)

Tantivejkul, Loberg, Mawocha, Day, John, Pienta, Rubin, Pienta: "PAR1-mediated NFkappaB activation promotes survival of prostate cancer cells through a Bcl-xL-dependent mechanism." dans: Journal of cellular biochemistry, Vol. 96, Issue 3, pp. 641-52, (2005) (PubMed).

Nakayama, Kawato, Watanabe, Ohtsuka, Yoshida, Yokomizo, Sakamoto, Kuru, Ohta, Hoshino, Yoshida, Ishida, Cho, Palme, Zhang, Lee, Watkins: "MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 3: Optimization of potency in the pyridopyrimidine series through the application of a pharmacophore model." dans: Bioorganic & medicinal chemistry letters, Vol. 14, Issue 2, pp. 475-9, (2003) (PubMed).

Détails sur PAR1

Antigène: PAR1 (F2R) (Coagulation Factor II (thrombin) Receptor (F2R))

Autre désignation: PAR1

Sujet: PAR1: Prader-Willi/Angelman region-1 .

ID gène: 145624

Pathways: Nuclear Receptor Transcription Pathway, Skeletal Muscle Fiber Development, Positive Regulation of Endopeptidase Activity, Protein targeting to Nucleus